Sign in to follow

Litigation Daily

Litigators of the Week: After Two Big Wins for Plaintiffs, a Defense Verdict for Infant Formula Makers

Juries hit Mead Johnson and Abbott Laboratories with verdicts of $60 million and $495 million respectively earlier this year in cases linking an intestinal disease with formula given to premature babies in hospitals. Covington's Phyllis Jones and Kirkland's Jim Hurst led teams that secured a defense verdict for the companies in Missouri state court last week.
11 minute read

Law.com

Judge Dismisses Microplastics Suit Against Evian's 'Natural Spring Water'

In "Daly v. Danone Waters of America," the court determined that the plaintiffs' claims were preempted by federal regulation.
5 minute read

Litigation Daily

Litigators of the Week: An Early Knockout Win in the Decongestant MDL

After Andrew Soukup of Covington & Burling and Jay Lefkowitz of Kirkland & Ellis argued the motion to dismiss for the defendants, a federal judge in Brooklyn found state law claims concerning the effectiveness of decongestants were preempted by federal law and that the plaintiffs lacked standing to pursue their RICO claims.
13 minute read

Law.com

Abbott, Mead Johnson Win Defense Verdict Over Preemie Infant Formula

In closing arguments on Wednesday, plaintiff's lawyer Timothy Cronin asked jurors for $6 billion in punitive damages.
5 minute read

New York Law Journal

Decongestant MDL on Death's Door After Judge Strikes Key Claims

On Tuesday, U.S. District Judge Brian Cogan in New York dismissed key consumer claims in the multidistrict litigation against drugmakers of decongestants including Sudafed PE and NyQuil Severe Cold & Flu.
5 minute read

National Law Journal

'Good Law': DC Judge Denies Hogan Lovells Motion in Big Pharma Dispute

"The Court further finds that FDA did not act arbitrarily by excluding part of Entresto's dosing regimen from MSN's generic drug label," U.S. District Judge Dabney L. Friedrich wrote in her memorandum opinion unsealed with minimal redactions. "For these reasons, the Court will uphold FDA's approval of MSN's generic drug."
3 minute read

The Recorder

Who Got the Work: Saul Ewing Team Appears for Samsung Bioepis in Amgen Patent Case

California-based Amgen has filed a patent infringement suit to stop Samsung Bioepis from developing bone-treatment drugs that would rival two of its top-performing products.
4 minute read

Law.com

Quinn Emanuel Client Sues Biotech Company, Seeking $100M Over Allegedly Breached COVID-19 Test Kit Agreement

Upon obtaining approval from the Food and Drug Administration, the plaintiffs claim the defendants "unilaterally cancelled plaintiffs' manufacturing and distribution rights, and unfairly demanded that plaintiffs agree to new, less favorable terms, or else defendants would choose a new manufacturer and cut plaintiffs out entirely. When plaintiffs refused to capitulate to defendants' deceptive scheme, defendants made good on their threats by deserting the deal and ignoring plaintiffs' demands for just compensation," according to the complaint.
3 minute read

The Legal Intelligencer

SEC Agrees to Dismiss Civil Suit Against Former Pharma CIO Over Alleged Insider Trading

"We are delighted that Ram has been fully vindicated of these meritless allegations," former Mylan executive Ramkumar V. Rayapureddy's lead counsel, Adam Lurie, a partner at Linklaters, said of the outcome. "He has shown remarkable courage and resilience throughout this long injustice and is looking forward to moving on with his life and his career."
3 minute read

National Law Journal

'Irreparable Harm'?: US Judge Denies Big Pharma Motion to Halt FDA-Approved Generic Drug

"Novartis has not established on the current record that it is likely to suffer irreparable harm if injunctive relief is not granted," U.S. District Judge Dabney L. Friedrich wrote in her memorandum opinion denying Novartis's motion for a preliminary injunction without prejudice.
3 minute read

More from ALM

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

Resources

  • Yearly Roundup: Strategic Insights for Law Firm Decision Making

    Brought to you by CARET Legal

    Download Now

  • Lex Machina Contracts: Commercial Litigation Report 2024

    Brought to you by LexisNexis®

    Download Now

  • White Collar Investigation Practice: Global Expertise in Complex Investigations

    Brought to you by HaystackID

    Download Now

  • Criminal Division's Evaluation of Corporate Compliance Programs: September 2024 Updates Review

    Brought to you by NAVEX Global

    Download Now